COMMUNITY-ACQUIRED PNEUMONIA (CAP)

This study checks how well the Prevnar 20 (PCV20) vaccine works in real life for people 65 and older. Researchers will look at medical records from over 22 million Medicare patients to see if the vaccine lowers the risk of serious lung infections like pneumonia. No new treatments…

This study was designed to test whether adding two experimental agents (nogapendekin alfa inbakicept and iNKT cells) to standard care could lower the risk of death within 28 days in critically ill adults with severe community-acquired pneumonia, with or without sepsis or acute re…

This study looks at 500 patients with severe breathing failure from pneumonia who are using a breathing mask (non-invasive ventilation). Researchers measure their energy needs, muscle function, and blood markers to find patterns that could help tailor treatments and reduce the ne…

This study looks at ways to help doctors prescribe fewer antibiotics for common respiratory infections in children, like ear infections, strep throat, sinusitis, and pneumonia. Researchers will track antibiotic use in over 400 children seen at primary and urgent care clinics. The…